| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypertension, Vol 20, 118-127, Copyright © 1992 by American Heart Association
JI Goldhaber and JN Weiss
Oxygen free radicals are highly reactive compounds causing peroxidation of
lipids and proteins and are thought to play an important role in the
pathogenesis of reperfusion abnormalities including myocardial stunning,
irreversible injury, and reperfusion arrhythmias. Free radical accumulation
has been measured in ischemic and reperfused myocardium directly using
techniques such as electron paramagnetic resonance spectroscopy and tissue
chemiluminescence and indirectly using biochemical assays of lipid
peroxidation products. Potential sources of free radicals during ischemia
and reperfusion have been identified in myocytes, vascular endothelium, and
leukocytes. In several different experimental models exogenous free
radical-generating systems have been shown to produce alterations in
cardiac function that resemble the various reperfusion abnormalities
described above. Injury to processes involved in regulation of the
intracellular Ca2+ concentration may be a common mechanism underlying both
free radical- induced and reperfusion abnormalities. Direct effects of free
radicals on each of the known Ca(2+)-regulating mechanisms of the cell as
well as the contractile proteins and various ionic membrane currents have
been described. Free radicals also inhibit critical enzymes in anaerobic
and aerobic metabolic pathways, which may limit the metabolic reserve of
reperfused myocardium and contribute to intracellular Ca2+ overload.
Inhibiting free radical accumulation during myocardial ischemia/reperfusion
with free radical scavengers and inhibitors has been demonstrated to reduce
the severity of myocardial stunning, irreversible injury, and reperfusion
arrhythmias in many, but not all, studies. This evidence strongly
implicates free radical accumulation during myocardial ischemia/reperfusion
as an important pathophysiological mechanism of reperfusion abnormalities,
although many issues remain unresolved.
ARTICLES
Oxygen free radicals and cardiac reperfusion abnormalities
Division of Cardiology, UCLA School of Medicine 90024.
This article has been cited by other articles:
![]() |
W.-m. Zhao, H.-p. Qi, Y. Liu, W. Chen, J. Xie, Z.-y. Pan, H.-m. Han, L.-p. Chen, D.-l. Li, L.-y. Wang, et al. The Antiarrhythmic Effect and Possible Ionic Mechanisms of Pilocarpine on Animal Models Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 242 - 247. [Abstract] [PDF] |
||||
![]() |
K. M. Jaques-Robinson, R. Golfetti, S. S. Baliga, N. M. Hadzimichalis, and G. F. Merrill Acetaminophen Is Cardioprotective Against H2O2-Induced Injury In Vivo Experimental Biology and Medicine, October 1, 2008; 233(10): 1315 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, K. Patel, S. G. Connors, M. Mendonca, W. J. Welch, and C. S. Wilcox Acute antihypertensive action of Tempol in the spontaneously hypertensive rat Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3246 - H3253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Parihar and G. J. Brewer Mitoenergetic failure in Alzheimer disease Am J Physiol Cell Physiol, January 1, 2007; 292(1): C8 - C23. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujimoto, M. Ohno, S. Ayabe, H. Kobayashi, N. Ishizaka, H. Kimura, K.-i. Yoshida, and R. Nagai Carbon Monoxide Protects Against Cardiac Ischemia--Reperfusion Injury In Vivo via MAPK and Akt--eNOS Pathways Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1848 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gerrah, Y. Shargal, and A. Elami Impaired oxygenation and increased hemolysis after cardiopulmonary bypass in patients with glucose-6-phosphate dehydrogenase deficiency Ann. Thorac. Surg., August 1, 2003; 76(2): 523 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Rothstein, K. L. Byron, R. E. Reed, L. Fliegel, and P. A. Lucchesi H2O2-induced Ca2+ overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H598 - H605. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Shao, T. L. Vanden Hoek, Y. Qin, L. B. Becker, P. T. Schumacker, C.-Q. Li, L. Dey, E. Barth, H. Halpern, G. M. Rosen, et al. Baicalein attenuates oxidant stress in cardiomyocytes Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H999 - H1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wei, E. C. Rothstein, L. Fliegel, L. J. Dell'Italia, and P. A. Lucchesi Differential MAP kinase activation and Na+/H+ exchanger phosphorylation by H2O2 in rat cardiac myocytes Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1542 - C1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Dhalla, A. B. Elmoselhi, T. Hata, and N. Makino Status of myocardial antioxidants in ischemia-reperfusion injury Cardiovasc Res, August 18, 2000; 47(3): 446 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Levy, P. Bartha, A. Ben-Amotz, J. Gerald Brook, G. Dankner, S. Lin, and H. Hammerman Plasma Antioxidants and Lipid Peroxidation in Acute Myocardial Infarction and Thrombolysis J. Am. Coll. Nutr., August 1, 1998; 17(4): 337 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Kourie Interaction of reactive oxygen species with ion transport mechanisms Am J Physiol Cell Physiol, July 1, 1998; 275(1): C1 - C24. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sabri, K. L. Byron, A. M. Samarel, J. Bell, and P. A. Lucchesi Hydrogen Peroxide Activates Mitogen-Activated Protein Kinases and Na+-H+ Exchange in Neonatal Rat Cardiac Myocytes Circ. Res., June 1, 1998; 82(10): 1053 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Crestanello, J. Kamelgard, D. M. Lingle, S. A. Mortensen, M. Rhode, and G. J. R. Whitman ELUCIDATION OF A TRIPARTITE MECHANISM UNDERLYING THE IMPROVEMENT IN CARDIAC TOLERANCE TO ISCHEMIA BY COENZYME Q10 PRETREATMENT J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 443 - 450. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |